A Study Evaluating Physical Activity and Joint Health in Severe Haemophilia A Patients ≥12 Years Treated Once Weekly With Efanesoctocog Alfa
NCT05817812
·
clinicaltrials.gov ↗
PHASE3
Phase
ACTIVE_NOT_RECRUITING
Status
93
Enrollment
INDUSTRY
Sponsor class
Conditions
Hemophilia A, Severe
Interventions
DRUG:
Efanesoctocog alfa
Sponsor
Swedish Orphan Biovitrum
Collaborators
[object Object]